Newsy

Blind people will be able to see and paralyzed people will control technology: Musk announced two new Neuralink devices.

• Telepathy lets people with paralysis control a computer and gadgets with the power of thought (1,024 electrodes); it is currently undergoing clinical trials.

• Blindsight transmits images from cameras directly to the visual cortex to restore sight to the blind. It has Breakthrough Device status from the FDA, but is still at the preclinical stage.

Both implants are installed by a specialized R1 surgical robot, which bypasses the brain's blood vessels.

OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical teams coordinate drug development. The team and technology will be combined with OpenAI's AI models and tools.

In the US, the path from identifying a therapeutic target to drug approval takes 10-15 years on average. The company hopes AI will help shorten this time.

Men in the US spend 16% more on Botox than women: the average man pays $529 per neurotoxin procedure in the US.

The most active men are Gen X, followed by millennials. The trend is most noticeable in the western US.